299 related articles for article (PubMed ID: 8684154)
21. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.
Kowada A
Epidemiol Infect; 2018 Oct; 146(14):1834-1840. PubMed ID: 30056808
[TBL] [Abstract][Full Text] [Related]
22. Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.
Yeh JM; Kuntz KM; Ezzati M; Goldie SJ
Int J Cancer; 2009 Jan; 124(1):157-66. PubMed ID: 18823009
[TBL] [Abstract][Full Text] [Related]
23. The health economics of Helicobacter pylori infection.
Moayyedi P
Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282
[TBL] [Abstract][Full Text] [Related]
24. The cost effectiveness of Helicobacter pylori population screening-economic evaluation alongside a randomised controlled trial with 13-year follow-up.
Høgh MB; Kronborg C; Hansen JM; Schaffalitzky de Muckadell OB
Aliment Pharmacol Ther; 2019 Apr; 49(8):1013-1025. PubMed ID: 30854700
[TBL] [Abstract][Full Text] [Related]
25. Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration.
Schulz TR; McBryde ES; Leder K; Biggs BA
PLoS One; 2014; 9(9):e108610. PubMed ID: 25268809
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Helicobacter pylori infection to reduce gastric cancer incidence: uncertain benefits of a community based programme in Australia.
Forbes GM; Threlfall TJ
J Gastroenterol Hepatol; 1998 Nov; 13(11):1091-5. PubMed ID: 9870793
[TBL] [Abstract][Full Text] [Related]
27. Cost-benefit analysis of Helicobacter pylori screening.
Leivo T; Salomaa A; Kosunen TU; Tuominen R; Färkkilä M; Linna M; Sintonen H
Health Policy; 2004 Oct; 70(1):85-96. PubMed ID: 15312711
[TBL] [Abstract][Full Text] [Related]
28. Varying efficacy of Helicobacter pylori eradication regimens: cost effectiveness study using a decision analysis model.
Duggan AE; Tolley K; Hawkey CJ; Logan RF
BMJ; 1998 May; 316(7145):1648-54. PubMed ID: 9603748
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori-associated ulcer bleeding: should we test for eradication after treatment?
Pohl H; Finlayson SR; Sonnenberg A; Robertson DJ
Aliment Pharmacol Ther; 2005 Sep; 22(6):529-37. PubMed ID: 16167969
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness Analysis of the Helicobacter Pylori Screening Programme in an Asymptomatic Population in China.
Feng T; Zheng Z; Xu J; Cao P; Gao S; Yu X
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011621
[TBL] [Abstract][Full Text] [Related]
31. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
32. Asia-Pacific consensus guidelines on gastric cancer prevention.
Fock KM; Talley N; Moayyedi P; Hunt R; Azuma T; Sugano K; Xiao SD; Lam SK; Goh KL; Chiba T; Uemura N; Kim JG; Kim N; Ang TL; Mahachai V; Mitchell H; Rani AA; Liou JM; Vilaichone RK; Sollano J;
J Gastroenterol Hepatol; 2008 Mar; 23(3):351-65. PubMed ID: 18318820
[TBL] [Abstract][Full Text] [Related]
33. Can eradicating H pylori prevent gastric cancer?
Walt B; Kerr G
Lancet; 1998 Mar; 351(9106):887. PubMed ID: 9525379
[No Abstract] [Full Text] [Related]
34. Helicobacter pylori and risk for gastric adenocarcinoma.
Asghar RJ; Parsonnet J
Semin Gastrointest Dis; 2001 Jul; 12(3):203-8. PubMed ID: 11478753
[TBL] [Abstract][Full Text] [Related]
35. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
36. Strategy for eliminating gastric cancer in Japan.
Asaka M; Kato M; Graham DY
Helicobacter; 2010 Dec; 15(6):486-90. PubMed ID: 21073603
[TBL] [Abstract][Full Text] [Related]
37. A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers.
Davies R; Crabbe D; Roderick P; Goddard JR; Raftery J; Patel P
Health Care Manag Sci; 2002 Nov; 5(4):249-58. PubMed ID: 12437272
[TBL] [Abstract][Full Text] [Related]
38. Screening to Identify and Eradicate Helicobacter pylori Infection in Teenagers in Japan.
Akamatsu T; Okamura T; Iwaya Y; Suga T
Gastroenterol Clin North Am; 2015 Sep; 44(3):667-76. PubMed ID: 26314676
[TBL] [Abstract][Full Text] [Related]
39. Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.
Fuccio L; Zagari RM; Minardi ME; Bazzoli F
Aliment Pharmacol Ther; 2007 Jan; 25(2):133-41. PubMed ID: 17229238
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness analysis of different screening strategies for helicobacter pylori infection in Iran: A model-based evaluation.
Yousefi M; Rezaei S; Khoshbaten M; Sarmasti M
Helicobacter; 2023 Dec; 28(6):e13027. PubMed ID: 37839058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
